Dapagliflozin
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5311 publications
Antialbuminuric Effect of Dapagliflozin Correlates With Urinary Epidermal Growth Factor in Real-World Patients With Diabetic Kidney Disease.
Journal: Kidney medicine
Published: October 31, 2026
Deciphering the neuroprotective signaling of SGLT2 inhibitors in Alzheimer's disease.
Journal: Journal of Alzheimer's disease : JAD
Published: October 30, 2026
Saxagliptin Attenuates Thioacetamide-Induced Liver Fibrosis in Rats in Association with Changes in SIRT1/Nrf2/HO-1 Signaling, Oxidative Stress, and Apoptosis.
Journal: Toxicology mechanisms and methods
Published: October 22, 2026
Early Changes in Left Atrial Mechanics During Sodium-Glucose Cotransporter-2 Inhibitor Therapy in Heart Failure with Preserved Ejection Fraction.
Journal: Anatolian journal of cardiology
Published: October 20, 2026
Dapagliflozin After Transcatheter Aortic Valve Implantation According to Frailty in DapaTAVI Trial.
Journal: Journal of the American Heart Association
Published: October 16, 2026
Nickel-catalyzed one-pot C-H alkylation of (hetero)arenes enabled by in situ electrophilic iodination and reductive coupling with alkyl pyridinium salts.
Journal: Organic & biomolecular chemistry
Published: October 15, 2026
A preliminary study on the protective effect of dapagliflozin on multi-organ function in the early stage of sepsis
Journal: Zhonghua nei ke za zhi
Published: October 10, 2026
Dapagliflozin and ventricular repolarization across heart failure phenotypes.
Journal: Current medical research and opinion
Published: October 07, 2026
Pharmacometric analysis of dapagliflozin for triglyceride-lowering effects in Japanese patients with type 2 diabetes mellitus based on long-term real-world data and experimental analysis of dyslipidemia model rats.
Journal: Xenobiotica; the fate of foreign compounds in biological systems
Published: October 07, 2026
Dapagliflozin reduces the incidence of acute kidney injury after cardiac surgery
Journal: Die Anaesthesiologie
Published: October 06, 2026
Dapagliflozin for attenuating early anthracycline-associated cardiac changes (DAPA-AIC): a randomized, double-blind, placebo-controlled trial.
Journal: Future science OA
Published: October 06, 2026
Last Updated: 11/08/2026